Bioadhesive drug formulations for oral transmucosal delivery
First Claim
Patent Images
1. A bioadhesive tablet, comprising:
- from about 2.5 to about 100 micrograms of sufentanil, a bioadhesive material and pharmaceutically acceptable excipients, wherein said bioadhesive tablet;
(i) provides for adherence to the oral mucosa of said subject during the period of drug delivery such that the majority of drug is delivered across the oral mucosa, (ii) generates a minimal saliva response and minimal swallowing of drug, and (iii) said bioadhesive tablet is a substantially homogeneous composition with a volume of from about 3.0 to about 15.0 microliters (mcl).
4 Assignments
0 Petitions
Accused Products
Abstract
Formulations for controlled delivery of oral transmucosal medications are provided. The formulations are characterized as hydrogel-forming or eroding-types which are bioadhesive and provide for controlled and sustained release of the medication such that enhanced bioavailability and efficacy is provided.
-
Citations
35 Claims
-
1. A bioadhesive tablet, comprising:
from about 2.5 to about 100 micrograms of sufentanil, a bioadhesive material and pharmaceutically acceptable excipients, wherein said bioadhesive tablet;
(i) provides for adherence to the oral mucosa of said subject during the period of drug delivery such that the majority of drug is delivered across the oral mucosa, (ii) generates a minimal saliva response and minimal swallowing of drug, and (iii) said bioadhesive tablet is a substantially homogeneous composition with a volume of from about 3.0 to about 15.0 microliters (mcl).- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)
Specification